Grifols SA
F:OZTA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Grifols SA
F:OZTA
|
ES |
|
T
|
Trimble Inc
XMUN:TB5
|
US |
|
Nick Scali Ltd
F:NJN
|
AU |
|
AngloGold Ashanti Ltd
F:AOD1
|
ZA |
|
CELM Inc
TSE:7367
|
JP |
|
A
|
AP Moeller - Maersk A/S
F:DP4A
|
DK |
|
B
|
BP PLC
XMUN:BPE5
|
UK |
|
E
|
Endeavour Silver Corp
SWB:EJD
|
CA |
|
C
|
Constellation Brands Inc
F:CB1A
|
US |
|
Weibo Corp
F:2WBA
|
CN |
|
Noble Corporation PLC
F:85V1
|
US |
|
P
|
Permanent TSB Group Holdings PLC
OTC:ILPMF
|
IE |
|
Danone SA
F:BSND
|
FR |
|
B
|
BHP Group Ltd
F:BHP1
|
AU |
|
National Bank of Canada
TSX:NA
|
CA |
|
Recreate ASA
F:6R4
|
NO |
|
C
|
Corcept Therapeutics Inc
SWB:HTD
|
US |
|
K
|
Koninklijke Philips NV
MIL:PHIA
|
NL |
|
Naspers Ltd
F:NNW
|
ZA |
|
K
|
Krakatau Steel (Persero) Tbk PT
XMUN:07K
|
ID |
|
L
|
Lenzing AG
XBER:LEN
|
AT |
|
V
|
Volvo AB
XMUN:VOL1
|
SE |
|
S
|
Stora Enso Oyj
XBER:ENUN
|
FI |
|
E.ON SE
F:EOAN
|
DE |
Bankruptcy Probability
Grifols SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Grifols SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ES |
|
Grifols SA
MAD:GRF
|
6.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
107.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
74.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
60B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Grifols SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Grifols SA has total debt of 8.5B EUR. This includes both short-term (0 EUR) and long-term (8.5B EUR) debt.
You can find a full breakdown on its Balance Sheet.